Rabia Khan

CEO @ Serna Bio arrow icon

About Rabia Khan

Rabia Khan, CEO with a PhD in Human Genetics and an MBA, has held influential roles in major biotech firms and is dedicated to promoting diversity in STEM.

Known information

Rabia Khan, born and raised in Pakistan, is a distinguished leader in the biotechnology sector, currently serving as a CEO. She holds a PhD in Human Genetics and an MBA, equipping her with a robust foundation in both scientific and business management. Previously, Khan was the Managing Director of Discovery Sciences at Sensyne Health Plc, where she was instrumental in establishing the company’s scientific strategy, building its data science and discovery teams, and leading pharmaceutical partnerships with major industry players such as Bayer, BMS, Roche, and Alexion. Her career also includes senior positions at BenevolentAI and Meta. Khan is deeply committed to enhancing diversity within the STEM fields. Her efforts and leadership have earned her recognition as one of the 50 Movers and Shakers in BioBusiness and one of the 30 Rising Leaders in Biotech in 2020.

About Serna Bio

Serna Bio, formerly Ladder Therapeutics (LTX), is a biotech company specializing in the development of novel therapeutics targeting the transcriptome for diseases with high unmet medical needs.

report flag Report inaccurate information

People similar to Rabia Khan

Danny Incarnato, CSO and PhD in molecular biotechnologies, is renowned for his pioneering work in RNA structure and computational biology.

Tim Allen

Head of ChemAI @ Serna Bio

Tim Allen is the Head of ChemAI, known for his contributions to defining chemical rules for RNA binders and the development of STaR rules.

Francisco Guedes is a research scientist known for his contributions to computational biology, with an educational background from MIT, the University of Cambridge, and Brown University.

Unlock exclusive insights

Sign up to reveal more information.

loader Sign up for free